• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

N-(4-Ethylphenyl)sulfonylglycine: A Comprehensive Overview

N-(4-Ethylphenyl)sulfonylglycine (CAS No. 670255-99-9) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as ESG, is characterized by its unique structural features and potential biological activities. In this comprehensive overview, we will delve into the chemical properties, synthesis methods, biological applications, and recent research advancements of N-(4-Ethylphenyl)sulfonylglycine.

Chemical Structure and Properties

N-(4-Ethylphenyl)sulfonylglycine is a sulfonyl glycine derivative with the molecular formula C₁₀H₁₃NO₄S. The compound features a sulfonyl group attached to a 4-ethylphenyl ring and a glycine moiety. The presence of these functional groups imparts distinct chemical properties to the molecule, making it suitable for various applications in medicinal chemistry. The sulfonyl group enhances the compound's reactivity and stability, while the glycine moiety contributes to its solubility and bioavailability.

Synthesis Methods

The synthesis of N-(4-Ethylphenyl)sulfonylglycine can be achieved through several routes, each with its own advantages and limitations. One common method involves the reaction of 4-ethylbenzenesulfonyl chloride with glycine in the presence of a base such as sodium hydroxide or potassium carbonate. This reaction proceeds via nucleophilic substitution, leading to the formation of the desired product. Another approach involves the use of 4-ethylbenzenesulfonyl fluoride, which can react with glycine under milder conditions.

Recent advancements in green chemistry have also led to the development of more environmentally friendly synthesis methods. For instance, researchers have explored the use of microwave-assisted synthesis to enhance reaction efficiency and reduce waste generation. These methods not only improve the yield and purity of N-(4-Ethylphenyl)sulfonylglycine but also align with sustainable chemistry principles.

Biological Applications

N-(4-Ethylphenyl)sulfonylglycine has shown promising biological activities that make it a valuable candidate for pharmaceutical development. One of its key applications is as an inhibitor of specific enzymes involved in metabolic pathways. Studies have demonstrated that N-(4-Ethylphenyl)sulfonylglycine can effectively inhibit the activity of certain kinases, making it a potential lead compound for the treatment of diseases such as cancer and inflammatory disorders.

In addition to its enzymatic inhibition properties, N-(4-Ethylphenyl)sulfonylglycine has been investigated for its anti-inflammatory effects. Preclinical studies have shown that it can reduce inflammation by modulating the expression of pro-inflammatory cytokines such as TNF-α and IL-6. These findings suggest that N-(4-Ethylphenyl)sulfonylglycine may have therapeutic potential in conditions characterized by chronic inflammation.

Clinical Trials and Research Developments

The potential therapeutic applications of N-(4-Ethylphenyl)sulfonylglycine have prompted several clinical trials to evaluate its safety and efficacy in human subjects. Early-phase clinical trials have shown promising results, with no significant adverse effects reported at therapeutic doses. These trials have focused on assessing the compound's pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME).

Ongoing research is also exploring the combination therapy potential of N-(4-Ethylphenyl)sulfonylglycine. For instance, studies are investigating its synergistic effects when used in conjunction with other anti-inflammatory agents or chemotherapeutic drugs. These combination therapies aim to enhance treatment outcomes while minimizing side effects.

Conclusion

In conclusion, N-(4-Ethylphenyl)sulfonylglycine (CAS No. 670255-99-9) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological activities make it a promising candidate for the development of novel therapeutic agents. Ongoing research continues to uncover new applications and optimize its use in various medical settings. As our understanding of this compound deepens, it is likely to play an increasingly important role in advancing healthcare solutions.

• 1922-60-7(2-(4-sulfamoylbenzenesulfonamido)acetic acid)
• 96919-70-9(Glycine, N-[(4-ethylphenyl)sulfonyl]-, monoammonium salt (9CI))
• 4816-81-3(N-(4-Methylphenyl)sulfonylalanine)
• 1080-44-0(N-p-Tosylglycine)
• 85471-45-0(D-Alanine, N-[(4-methylphenyl)sulfonyl]-)
• 790270-98-3(2-(3-Acetylbenzenesulfonamido)acetic Acid)
• 21957-58-4(N-Tosyl-L-alanine)
• 159855-98-8(2-(4-tert-butylbenzenesulfonamido)propanoic acid)
• 159855-97-7(2-(4-tert-butylbenzenesulfonamido)acetic acid)
• 477483-07-1(Benzenesulfonamide, 4-ethyl-N-(2-hydroxyethyl)- (9CI))